A

Andrew Wong

About

Detail

Machine Learning Engineer | AI & Bioinformatics
New Haven, Connecticut, United States

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Beacon Biosignals
    Manager, Machine Learning Algorithms
    Beacon Biosignals
    Jul 2026 - Current (3 months)
  • Harbinger Health
    Assoc. Principal Machine Learning Engineer
    Harbinger Health
    Jul 2024 - Jul 2026 (2 years 1 month)
    Building next-generation cancer screening platforms by integrating deep learning with molecular biology.

    - Generative AI for Genomics: Diffusion Models to synthesize high-fidelity biological data, overcoming data scarcity hurdles in oncology training sets.

    - Scalable MLOps: Architected distributed training workflows using AWS and Ray, significantly reducing experiment turnaround time for large-scale genomic models.

    - Biomarker Discovery: Engineered novel biological features to identify early-cancer signals with high sensitivity.

    - Production Deployment: Led the productization of research models into validated production inference pipelines, ensuring strict versioning and reproducibility.
  • S
    Owner & Principal Engineer
    Sagio Dev
    Mar 2022 - Jul 2024 (2 years 5 months)
    1. Founded and scaled a Generative AI media platform from zero to 2,000+ paying subscribers.

    - Full-Stack Architecture: Architected high-performance web infrastructure to support rapid user growth and high-throughput content generation.

    - Product Growth: Drove user acquisition through technical SEO and content strategy, establishing a leading voice in the Stable Diffusion/Generative AI community.

    2. Deliver custom ML and NLP solutions for biotech clients.

    - Visual LLMs: Automated large-scale image labeling pipelines by deploying Visual Language Models (VLMs) to annotate cell imagery.

    - Computer Vision: Developed custom segmentation algorithms to extract biological signals from microscop
  • Thermo Fisher Scientific
    Sr Manager, Engineering
    Thermo Fisher Scientific
    Dec 2013 - Jul 2024 (10 years 8 months)
    Directed technical strategy and software development for FDA-regulated clinical NGS sequencers (Oncology), overseeing the full lifecycle from R&D to commercial launch.

    - Signal Processing & ML: Spearheaded the development of signal processing pipelines and machine learning-driven data analytics, significantly improving base-calling accuracy and variant detection.

    - FDA Compliance: Led software innovation within strict regulatory frameworks (Class II/III devices), ensuring compliant design controls without sacrificing development velocity.

    - Bioinformatics & Assay Co-Design: Managed the convergence of bioinformatics algorithms and wet-lab assay optimization, resulting in robust automated workflows for cancer
  • Roche Sequencing USA
    Sr. Research Scientist, Algorithms
    Roche Sequencing USA
    Mar 2008 - Nov 2013 (5 years 9 months)
    Pioneering NGS Tech: Developed the core signal processing and base-calling pipeline for the industry's first commercial NGS sequencer.

    100% Performance Gain: Doubled read length and throughput by inventing and deploying novel machine learning algorithms within the data processing pipeline.
Education verified_user 0% verified
  • University of Massachusetts Amherst
    Ph.D, Polymer Science and Engineering
    University of Massachusetts Amherst
    Jan 2004 - Jan 2008 (4 years 1 month)
    Langevin dynamics molecular simulation of single polymer under geometrical confinement. Theoretical studies of interaction between DNA and nanopore devices.
  • C
    M.Phil, Physics
    Chinese University of Hong Kong
    Jan 2001 - Jan 2003 (2 years 1 month)
    Computational physics research on complex fluids.
Publications verified_user 0% verified
  • J
    Polymer confinement and translocation
    Jul
  • T
    Polymer translocation through α-hemolysin pore with tunable polymer-pore electrostatic interaction
    The Journal of chemical physics Jul
This is a community-created genome.